No Data
No Data
Express News | Tharimmune Inc - Board Expands to Nine Members - SEC Filing
Express News | Tharimmune Says FDA Confirmed No Additional Trials Appear To Be Necessary Prior To A 505(b)(2) New Drug Application Submission
Tharimmune Strengthens Strategic Leadership With the Appointment of Vincent LoPriore to Its Board of Directors
Tharimmune Reports Preclinical Data for Dual-Target Biologics
Express News | Fw: [Ext] News: Tharimmune Announces Positive Data With Novel Biparatopic Pd-1/Vegf and Multispecific Her2/Her3 Biologics Leveraging Proprietary Epiclick(Tm) Technology
Tharimmune Announces Preclinical Data For HS1940
G3636G : u r our MVP all the times. txs and best regards to your effort to keep us sane and positively
105360556小强 : Thank you.
Entered a short position by mistake yesterday, and today made up a little.
Trailside22 : thx Dr.
105548513 : can you help me..
Strain :
View more comments...